Mostafa M. Bahaa - Publications

Adiponectin Signaling as an Immunometabolic Regulator in COVID-19: Mechanistic Insights and Therapeutic Potential.

Journal: Immunological investigations

Published: July 21, 2026

Norcantharidin attenuates amiodarone-induced pulmonary fibrosis via modulating miRNA-30a/GSK-3β/β-catenin and oxidative-inflammatory pathways.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 10, 2026

Mixture design-modelling and optimization of ketoprofen solid lipid nanoparticles for augmented anti-inflammatory activity following pharmacodynamic evaluation in rats.

Journal: Pharmaceutical development and technology

Published: May 14, 2026

SIRT1 in brain aging: molecular mechanisms and therapeutic potential of pharmacological and natural modulators.

Journal: Biogerontology

Published: April 04, 2026

Integrated biomarkers of oxidative stress NLRP3 inflammasome and kynurenine pathway reflect disease severity and diagnostic discrimination in depression.

Journal: Scientific reports

Published: April 02, 2026

The cross-talk between GSK-3β, RKIP, and PTEN as potential targets for therapeutic implications in cancer: a comprehensive insight.

Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques

Published: March 19, 2026

Dapagliflozin mitigates acute pancreatitis induced by L-arginine in Rats through modulation of TLR-4/NF-κB/NLRP3 pathway: integrated biochemical, histopathological, and in silico study.

Journal: Inflammopharmacology

Published: February 03, 2026

Impact of COVID-19 vaccination and vaccine type on morbidity and mortality in hospitalized patients: a retrospective cohort study in Egypt.

Journal: Frontiers in microbiology

Published: January 20, 2026

Immunomodulatory and Anti-Inflammatory Effects of Ketotifen Versus Vitamin E in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Pilot Study.

Journal: Drug design, development and therapy

Published: January 04, 2026

Modulation of mTOR, NLRP3, and Nrf2/HO-1 signaling by atorvastatin and nitazoxanide in experimental ulcerative colitis.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: January 03, 2026

Survival and renal outcomes of mucormycosis infection and its treatment regimens in resource-limited settings: a retrospective case series.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: November 19, 2025

Ulcerative colitis, pathophysiological mechanisms and drug repurposing: a new therapeutic dawn-narrative review.

Journal: Inflammopharmacology

Published: October 13, 2025